<DOC>
	<DOCNO>NCT00140426</DOCNO>
	<brief_summary>The aim pilot study determine safety efficacy risperidone treatment anorexia nervosa . Hypothesis 1 : Subjects risperidone show significant decrease body image distortion Eating Disorder Inventory -2 score subject placebo . Hypothesis 2 : Subjects risperidone reach maintain 90 % Ideal body weight sooner control .</brief_summary>
	<brief_title>A Double-blind , Placebo Controlled Trial Risperidone Treatment Anorexia Nervosa</brief_title>
	<detailed_description>The lack effective medication symptom anorexia nervosa ( AN ) , combine early promising finding case report ( Risperidone Olanzapine ) one open study olanzapine lead increase use medication individual AN . This double-blind placebo control study risperidone attempt determine risperidone effective decreasing core symptom anorexia nervosa decrease length time require reach maintain 90 % Ideal body weight . The safety risperidone population also examine monitor Extrapyramidal Symptoms , Tardive Dyskinesia , Electrocardiograms 's , Resting Energy Expenditure , liver enzymes blood chemistry . Other possible variable may mediate recovery process impact risperidone , leptin anxiety symptom also measure .</detailed_description>
	<mesh_term>Anorexia Nervosa</mesh_term>
	<mesh_term>Anorexia</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<criteria>Primary Diagnosis Anorexia Nervosa Female , age 1221 Active level care AN The Children 's Hospital , Denver As long primary dx AN , comorbid diagnosis may include . If take antidepressant , must stable dose 3 week prior enter study , dose antidepressant may change Phase 1 study . If choosing discontinue antidepressant medication , must medication 3 week prior begin study . If sexually active , must use birth control study monthly pregnancy test . Previous enrollment study prior admission Previous allergic reaction risperidone atypical neuroleptic Positive pregnancy test Neurologic disorder benign essential tremor Taking psychotropic medication antidepressant discontinue medication recommend . Active hepatic renal disease Wards state Males</criteria>
	<gender>Female</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Anorexia Nervosa</keyword>
	<keyword>Risperidone</keyword>
	<keyword>Atypical Neuroleptics</keyword>
	<keyword>Dopamine</keyword>
	<keyword>Leptin</keyword>
	<keyword>Body Image</keyword>
	<keyword>Adolescents</keyword>
</DOC>